AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.44B
PWJAX
Price
$33.57
Change
+$0.02 (+0.06%)
Updated
Jun 5 closing price
Net Assets
5.5B
Interact to see
Advertisement

AEPCX vs PWJAX

Header iconAEPCX vs PWJAX Comparison
Open Charts AEPCX vs PWJAXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.44B
PGIM Jennison International Opps A
Price$33.57
Change+$0.02 (+0.06%)
VolumeN/A
Net Assets5.5B
AEPCX vs PWJAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. PWJAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and PWJAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. PWJAX (5.5B). AEPCX pays higher dividends than PWJAX: AEPCX (0.32) vs PWJAX (0.00). AEPCX was incepted earlier than PWJAX: AEPCX (24 years) vs PWJAX (13 years). AEPCX (1.59) is less costly to investors than PWJAX (1.24). PWJAX is a more actively managed with annual turnover of: 44.00 vs. AEPCX (30.00). AEPCX has a lower initial minimum investment than PWJAX: AEPCX (250) vs PWJAX (1000). PWJAX annual gain was more profitable for investors over the last year : 7.98 vs. AEPCX (2.04). PWJAX return over 5 years is better than : 41.92 vs. AEPCX (14.22).
AEPCXPWJAXAEPCX / PWJAX
Total Expense Ratio1.591.09146%
Annual Report Gross Expense Ratio1.591.24128%
Fund Existence24 years13 years-
Gain YTD12.50213.07796%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets133B5.5B2,417%
Annual Yield % from dividends0.320.00-
Returns for 1 year2.047.9826%
Returns for 3 years14.8236.1641%
Returns for 5 years14.2241.9234%
Returns for 10 years20.67141.7115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.